LEXICON PHARMACEUTICALS, INC.
Company Stats
- Market Cap
- $834.3M
- as of Sep 30, 2026
- Shares Outstanding
- 445.0M
- Free Float
- 46.3%
Income Statement
- Revenue
- $49.8M
- Operating Income
- -$48.9M
- Net Income
- -$50.3M
- EBITDA
- -$48.3M
- Revenue Growth, 3Y
- 610.3%
- FCF Margin, 3Y Avg
- -4733.5%
- FCF Margin, Worst Year
- -13485.6%
Cash Flow
- Free Cash Flow
- -$67.9M
- FCF Yield
- -8.1%
- Owner FCF Yield
- -9.6%
Balance Sheet
- Cash & Equivalents
- $34.3M
Returns & Capital
- SBC, 3Y Avg
- $13.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $49.8M | -$67.9M | -136.2% |
| FY2024 | $31.1M | -$179.8M | -578.5% |
| FY2023 | $1.2M | -$162.4M | -13485.6% |
| FY2022 | $139,000 | -$90.2M | -64875.5% |
| FY2021 | $298,000 | -$88.2M | -29610.1% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 27, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back